Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Sections
Personal tools
Log in
 
You are here: Home › Collaborative Groups › G.I. and Other Associated Cancers Research Group › Developed the first EDRN large, multi-center cross-sectional trial of biomarkers for the early detection of hepatocellular carcinoma (HCC)

Developed the first EDRN large, multi-center cross-sectional trial of biomarkers for the early detection of hepatocellular carcinoma (HCC)

Demonstrated that des-carboxyprothrombin (DCP) has a significant advantage over AFP for detecting HCC with viral etiology
Announcement